Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

spanone

(135,765 posts)
Mon May 4, 2020, 03:54 PM May 2020

Before pandemic, Trump's stockpile chief put focus on biodefense. An old client benefited.

After Robert Kadlec was confirmed as President Trump’s top official for public health preparedness in 2017, he began pressing to increase government stocks of a smallpox vaccine. His office ultimately made a deal to buy up to $2.8 billion of the vaccine from a company that once paid Kadlec as a consultant, a connection he did not disclose on a Senate questionnaire when he was nominated.

Under the agreement struck last year with Emergent BioSolutions, Kadlec’s office at the Department of Health and Human Services is paying more than double the price per dose it had previously paid for the drug. Because Emergent is the only licensed maker of the vaccine, Kadlec’s office arrived at the price through negotiations with the company rather than through bidding.

The 10-year contract is part of an effort by Kadlec to bolster the nation’s stockpile of defenses against biological and chemical weapons, a focus he made a priority over preparing for a natural pandemic, an examination by The Washington Post found. Kadlec, a decorated veteran and biodefense expert, has argued for more than two decades in government and the private sector that the nation should devote more of its resources to preparing for bioweapon attacks.
----
Kadlec scaled back a long-standing interagency process for spending billions of dollars on stockpile purchases, diminishing the role of government experts and restricting decision-making to himself and a small circle of advisers, according to three former officials who spoke on the condition of anonymity to discuss sensitive matters.


--Paywall--
https://www.washingtonpost.com/investigations/before-pandemic-trumps-stockpile-chief-put-focus-on-biodefense-an-old-client-benefited/2020/05/04/d3c2b010-84dd-11ea-878a-86477a724bdb_story.html
2 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Before pandemic, Trump's stockpile chief put focus on biodefense. An old client benefited. (Original Post) spanone May 2020 OP
of course . his butt buddies and himself. AllaN01Bear May 2020 #1
The swamp thrives badhair77 May 2020 #2
Latest Discussions»General Discussion»Before pandemic, Trump's ...